Who owns Generate Biomedicines, Inc., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
Flagship Pioneering Fund VI, L.P.: 9.9% · 12,723,940 shares — Flagship Pioneering Fund VI General Partner LLC: 9.9% · 12,723,940 shares — Pioneering Medicines 02, LLC: 1.2% · 1,562,500 shares
Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Generate Biomedicines, Inc. they hold. Together these 98 managers report 79.02% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| Flagship Pioneering, LLC | $1.06B | 62,673,117 | 68.66% | 48.83% | June 30, 2026 |
| FMR LLC | $88.1M | 5,221,599 | 0.00% | 4.07% | June 30, 2026 |
96 more institutional holders behind a free account
See every manager reporting Generate Biomedicines, Inc., how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 49 funds hold 6.14% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| SMALLCAP World Fund Inc | $63.3M | 0.07% | 2.92% | June 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | $13.8M | 0.00% | 0.64% | June 30, 2026 |
47 more funds behind a free account
See every fund holding Generate Biomedicines, Inc. and what share of its net assets the position represents.
Sign up freeLoading...
